Precigen, INC Form 4 insider transactions

NASDAQ
Precigen's Chief Financial Officer, Harry Thomasian Jr., acquired 40,293 shares of common stock through the vesting and conversion of restricted stock units.
NASDAQ
Precigen's Chief Commercial Officer, Phil Tennant, converted 42,110 Restricted Stock Units into common stock, increasing his direct beneficial ownership.
NASDAQ
Precigen's President and CEO, Helen Sabzevari, acquired 321,100 shares of common stock through the vesting of restricted stock units.
NASDAQ
Precigen's Chief Operating Officer, Rutul R. Shah, acquired and converted 44,495 restricted stock units into common stock.
NASDAQ
Precigen's Chief Legal Officer, Donald P. Lehr, increased his direct beneficial ownership of common stock by 40,443 shares following the vesting and conversion of Restricted Stock Units.
NASDAQ
Randal J. Kirk, a Director and 10% owner of Precigen, Inc., acquired 143,678 shares of common stock through the vesting of restricted stock units.
NASDAQ
Precigen Director Nancy H. Agee converted 71,839 Restricted Stock Units into common stock following their vesting on March 13, 2026.
NASDAQ
Precigen Director Cesar L. Alvarez converted 71,839 Restricted Stock Units into common stock on March 13, 2026, increasing his direct beneficial ownership.
NASDAQ
Precigen Director Steven Frank converted 71,839 restricted stock units into common stock, increasing his direct ownership.
NASDAQ
Precigen Director Vinita D. Gupta converted 71,839 restricted stock units into common stock, increasing her direct beneficial ownership.
NASDAQ
Precigen Director Fred Hassan converted 71,839 Restricted Stock Units into common stock, increasing his direct beneficial ownership to 1,243,239 shares.
NASDAQ
Precigen Director Jeffrey B. Kindler converted 71,839 restricted stock units into common stock, increasing his direct beneficial ownership to 202,100 shares.
NASDAQ
Precigen Director James S. Turley acquired 71,839 shares of common stock on March 13, 2026, through the vesting of restricted stock units.
NASDAQ
Precigen Director and 10% owner Randal J. Kirk acquired additional common stock, restricted stock units, and stock options, increasing his beneficial ownership.
NASDAQ
Precigen Director James S. Turley acquired common stock, restricted stock units, and stock options on March 10, 2026, increasing his beneficial ownership.
NASDAQ
Precigen Director Jeffrey B. Kindler acquired common stock, restricted stock units, and stock options as part of his compensation.
NASDAQ
Precigen Director Fred Hassan received common stock, restricted stock units, and stock options as part of his annual compensation package, aligning his interests with shareholders.
NASDAQ
Precigen Director Vinita D. Gupta acquired common stock, restricted stock units, and stock options on March 10, 2026, increasing her beneficial ownership.
NASDAQ
Precigen Director Steven Frank acquired common stock, restricted stock units, and stock options as part of his compensation.
NASDAQ
Precigen Director Cesar L. Alvarez acquired common stock, restricted stock units, and stock options on March 10, 2026, increasing his beneficial ownership.
NASDAQ
Precigen Director Nancy H. Agee acquired common stock, restricted stock units, and stock options as part of her compensation on March 10, 2026.
NASDAQ
Precigen's Director and 10% owner, Randal J. Kirk, reported the sale of nearly 2 million shares of common stock for approximately $8.3 million.
NASDAQ
Jeffrey B. Kindler, a director at Precigen, Inc., sold 235,467 shares of common stock for a weighted average price of $3.6349 per share.
NASDAQ
Randal J. Kirk, a Director and 10% owner of Precigen, Inc., reported selling over 2.9 million shares of common stock across three transactions in November 2025.
NASDAQ
Jeffrey B. Kindler, a Director at Precigen, Inc., sold 174,360 shares of common stock for over $600,000 through pre-scheduled transactions.
NASDAQ
Precigen Director and 10% owner Randal J. Kirk reported the direct sale of 1,809,667 shares of common stock at a weighted average price of $3.41.
NASDAQ
Precigen's Chief Operating Officer, Rutul R. Shah, acquired 2,000 shares of common stock at $3.40 per share, increasing his beneficial ownership to 405,959 shares.
NASDAQ
Precigen's Chief Commercial Officer, Phil Tennant, acquired 6,000 shares of common stock at $3.58 per share, increasing his direct beneficial ownership to 65,031 shares.
NASDAQ
Precigen's Chief Financial Officer, Harry Thomasian Jr., reported increasing his direct beneficial ownership of common stock through recent open market purchases.
NASDAQ
Precigen Director and 10% owner Randal J. Kirk reported the conversion of preferred stock into common shares and subsequent sales totaling over $18.6 million through controlled entities.